Merus N.V. (MRUS)
USD 35.67
(-6.4%)
USD 35.67
(-6.4%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -83.46 Million USD | -381.92% |
| 2022 | 29.6 Million USD | 179.67% |
| 2021 | -37.16 Million USD | -35.66% |
| 2020 | -27.39 Million USD | -48.02% |
| 2019 | -18.5 Million USD | -151.77% |
| 2018 | 35.74 Million EUR | 140.21% |
| 2017 | 14.88 Million EUR | 962.36% |
| 2016 | 1.4 Million EUR | -2.56% |
| 2015 | 1.43 Million EUR | 108.14% |
| 2014 | -17.66 Million EUR | -78.67% |
| 2013 | -9.88 Million EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 7.33 Million USD | 0.69% |
| 2024 Q1 | 7.28 Million USD | 126.09% |
| 2024 Q3 | 11.77 Million USD | 60.56% |
| 2023 FY | -83.46 Million USD | -381.92% |
| 2023 Q4 | -27.91 Million USD | -17.35% |
| 2023 Q1 | -18.64 Million USD | -280.32% |
| 2023 Q2 | -15.45 Million USD | 17.09% |
| 2023 Q3 | -23.78 Million USD | -53.89% |
| 2022 Q1 | 11.65 Million USD | -20.76% |
| 2022 Q3 | -36.59 Million USD | -115.29% |
| 2022 Q4 | 10.33 Million USD | 128.25% |
| 2022 FY | 29.6 Million USD | 179.67% |
| 2022 Q2 | -16.99 Million USD | -245.84% |
| 2021 FY | -37.16 Million USD | -35.66% |
| 2021 Q2 | 12.37 Million USD | 48.25% |
| 2021 Q1 | 8.35 Million USD | -7.39% |
| 2021 Q4 | 14.7 Million USD | 7.61% |
| 2021 Q3 | 13.66 Million USD | 10.42% |
| 2020 FY | -27.39 Million USD | -48.02% |
| 2020 Q1 | 6.3 Million USD | -18.47% |
| 2020 Q2 | 6.05 Million USD | -3.89% |
| 2020 Q3 | 8.57 Million USD | 41.51% |
| 2020 Q4 | 9.01 Million USD | 5.2% |
| 2019 FY | -18.5 Million USD | -151.77% |
| 2019 Q4 | 7.72 Million USD | -13.84% |
| 2019 Q3 | 8.96 Million EUR | 38.69% |
| 2019 Q2 | 6.46 Million EUR | -25.23% |
| 2019 Q1 | 8.64 Million EUR | -10.73% |
| 2018 FY | 35.74 Million EUR | 140.21% |
| 2018 Q2 | 7.43 Million EUR | -38.81% |
| 2018 Q3 | 7.55 Million EUR | 1.61% |
| 2018 Q4 | 9.68 Million EUR | 28.28% |
| 2018 Q1 | 12.14 Million EUR | 165.35% |
| 2017 FY | 14.88 Million EUR | 962.36% |
| 2017 Q4 | 4.57 Million EUR | 214.7% |
| 2017 Q3 | -3.99 Million EUR | -208.23% |
| 2017 Q1 | 2.41 Million EUR | 105.59% |
| 2017 Q2 | 3.68 Million EUR | 52.98% |
| 2016 Q1 | 63.46 Thousand EUR | 201.3% |
| 2016 Q4 | 1.17 Million EUR | 17.18% |
| 2016 Q2 | 213.56 Thousand EUR | 236.51% |
| 2016 Q3 | 1 Million EUR | 368.57% |
| 2016 FY | 1.4 Million EUR | -2.56% |
| 2015 Q4 | 21.06 Thousand EUR | -80.7% |
| 2015 FY | 1.43 Million EUR | 108.14% |
| 2015 Q1 | 60.64 Thousand EUR | -87.31% |
| 2015 Q2 | 1.24 Million EUR | 1945.57% |
| 2015 Q3 | 109.14 Thousand EUR | -91.2% |
| 2014 FY | -17.66 Million EUR | -78.67% |
| 2014 Q4 | 477.88 Thousand EUR | 20.26% |
| 2014 Q3 | 397.37 Thousand EUR | 0.0% |
| 2013 FY | -9.88 Million EUR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AbCellera Biologics Inc. | 38.02 Million USD | 319.49% |
| Alkermes plc | 1.37 Billion USD | 106.071% |
| Agenus Inc. | 139.61 Million USD | 159.779% |
| Aptorum Group Limited | -1.11 Million USD | -7387.388% |
| Ardelyx, Inc. | 106.66 Million USD | 178.249% |
| Dyadic International, Inc. | 922.95 Thousand USD | 9142.785% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 496.282% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -47634.834% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -524.809% |
| Novavax, Inc. | 639.93 Million USD | 113.042% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -78.187% |
| Pyxis Oncology, Inc. | -2 Million USD | -4073.051% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -16051.265% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 538.277% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -188777.107% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -15737.005% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 15.024% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 10506.61% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -101681.727% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 161.7% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 1160.361% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 13.913% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 105.499% |
| AlloVir, Inc. | -398 Thousand USD | -20870.105% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 134.669% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 19784.202% |
| Bicycle Therapeutics plc | -129.52 Million USD | 35.561% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 69650.847% |
| ChromaDex Corporation | 50.78 Million USD | 264.358% |
| Chimerix, Inc. | 324 Thousand USD | 25859.573% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -167.781% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -7.556% |
| CRISPR Therapeutics AG | 240.95 Million USD | 134.637% |
| Precision BioSciences, Inc. | 40.47 Million USD | 306.219% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 14.977% |
| Fortress Biotech, Inc. | 57.85 Million USD | 244.264% |
| Fortress Biotech, Inc. | 57.85 Million USD | 244.264% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 603.475% |
| ImmuCell Corporation | 4.39 Million USD | 1998.445% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 21.354% |
| Immix Biopharma, Inc. | -5468.00 USD | -1526253.621% |
| Incyte Corporation | 3.44 Billion USD | 102.426% |
| Innoviva, Inc. | 261.06 Million USD | 131.969% |
| IO Biotech, Inc. | -756 Thousand USD | -10939.817% |
| Jaguar Health, Inc. | 7.72 Million USD | 1180.541% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -12469.43% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 169.694% |
| ContextLogic Inc. | 59 Million USD | 241.459% |
| MiMedx Group, Inc. | 266.84 Million USD | 131.277% |
| MEI Pharma, Inc. | 49.32 Million USD | 269.199% |
| NextCure, Inc. | -3.68 Million USD | -2165.5% |
| Onconetix, Inc. | -1.12 Million USD | -7304.507% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -188.115% |
| Opthea Limited | 21.72 Thousand USD | 384358.821% |
| Psyence Biomedical Ltd. | -240.00 USD | -34775323.333% |
| Vaxcyte, Inc. | -75 Million USD | -11.281% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -145490.162% |
| Precigen, Inc. | 106 Thousand USD | 78836.808% |
| Pharming Group N.V. | 220.1 Million USD | 137.919% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 16306.023% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 8371.657% |
| PureTech Health plc | -1.6 Million USD | -5106.551% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 176.031% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 53.993% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -84.139% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -279.593% |
| Acelyrin, Inc. | -115 Thousand USD | -72474.797% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -830275.246% |
| Summit Therapeutics Inc. | -2.05 Million USD | -3971.269% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -14516.64% |
| Senti Biosciences, Inc. | -2.68 Million USD | -3010.735% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 2160.257% |
| Elevation Oncology, Inc. | -39 Thousand USD | -213902.605% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -1639.496% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -2017.199% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 386.522% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 16926.818% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -151647.302% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 180.175% |
| Seer, Inc. | 7.02 Million USD | 1287.719% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 2006.373% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 487.38% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -70336.587% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -58141.754% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 13804.6% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 169.277% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 126.608% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -1669120.32% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 3342.464% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -164387.615% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 384.007% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -35874.576% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -16863.621% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -1075.838% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -17487.587% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -802409.769% |
| Soligenix, Inc. | 97.31 Thousand USD | 85867.299% |
| Century Therapeutics, Inc. | -10.8 Million USD | -672.144% |
| Kura Oncology, Inc. | -849 Thousand USD | -9730.508% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -24.376% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -56676.201% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 184.271% |
| Autolus Therapeutics plc | -4.86 Million USD | -1614.835% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 301.665% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -49579.176% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 188.111% |
| GRI Bio, Inc. | 10.84 Million USD | 869.865% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 3385.885% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -860.758% |
| IGM Biosciences, Inc. | -211.66 Million USD | 60.568% |
| INmune Bio, Inc. | 155 Thousand USD | 53945.817% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 234.747% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -5440.829% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -12770.769% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -285002.876% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 20861.447% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -4081.414% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -26564.861% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 188.355% |
| Verastem, Inc. | -62 Thousand USD | -134514.542% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 3527.557% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -31877.401% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 2857.219% |
| Histogen Inc. | 3.76 Million USD | 2314.407% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 14585.258% |
| Surrozen, Inc. | -27.23 Million USD | -206.504% |
| Organovo Holdings, Inc. | -5.38 Million USD | -1448.729% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -6826.915% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -225.422% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 516.223% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -4215102.828% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 1475.786% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -124225.596% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 153.919% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 57343.495% |
| Apollomics, Inc. | 127 Thousand USD | 65817.335% |
| Amarin Corporation plc | 165.54 Million USD | 150.417% |
| Mesoblast Limited | -9.81 Million USD | -750.341% |
| Turnstone Biologics Corp. | 16.5 Million USD | 605.64% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 24.462% |
| Synaptogenix, Inc. | -6347.00 USD | -1314867.953% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -163549.051% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 151.722% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 104.748% |
| Better Therapeutics, Inc. | -2.72 Million USD | -2958.3% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 25.588% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 124.687% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -731500.771% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -1233.243% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -7432.583% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 1240.489% |
| Insmed Incorporated | 239.63 Million USD | 134.828% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 2432.616% |
| OmniAb, Inc. | 14.66 Million USD | 669.039% |
| Alector, Inc. | -95.05 Million USD | 12.195% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 166.439% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -92.028% |
| Zai Lab Limited | 170.9 Million USD | 148.835% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 201.935% |
| Aura Biosciences, Inc. | -1.29 Million USD | -6344.866% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 64300.782% |
| Immunic, Inc. | -111 Thousand USD | -75090.105% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 626.435% |
| Veracyte, Inc. | 248.14 Million USD | 133.634% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 98.806% |
| FibroGen, Inc. | 128.9 Million USD | 164.747% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -14797952.482% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -615.367% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 102.456% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 21555.274% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 123.487% |
| TG Therapeutics, Inc. | 219.1 Million USD | 138.091% |
| Galecto, Inc. | -830 Thousand USD | -9955.544% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -5926.066% |
| Fortrea Holdings Inc. | 424 Million USD | 119.684% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 3.14% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -14619.756% |
| XBiotech Inc. | -1.74 Million USD | -4685.609% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -7432.583% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -79.598% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -10.495% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 213.702% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 596.703% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 121.453% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -68.109% |
| Vaxxinity, Inc. | -2.23 Million USD | -3635.945% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 125.543% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -637.038% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 441.34% |
| NexImmune, Inc. | -1.02 Million USD | -8042.761% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 1545674.37% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -1074.572% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.739% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -124791.161% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -2250.352% |
| Ainos, Inc. | -253.73 Thousand USD | -32793.244% |
| Pluri Inc. | 322 Thousand USD | 26019.57% |
| Prothena Corporation plc | -129.2 Million USD | 35.402% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 265.519% |
| Celularity Inc. | 6.75 Million USD | 1335.544% |
| Rallybio Corporation | -150 Thousand USD | -55540.677% |
| Cue Biopharma, Inc. | -32.6 Million USD | -155.96% |
| MeiraGTx Holdings plc | 287 Thousand USD | 29180.493% |
| Omeros Corporation | -69.77 Million USD | -19.608% |
| Humacyte, Inc. | -76.55 Million USD | -9.028% |
| Immunocore Holdings plc | 248.39 Million USD | 133.601% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -450.208% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 233.79% |
| Blueprint Medicines Corporation | 236.58 Million USD | 135.278% |
| CalciMedica, Inc. | -58 Thousand USD | -143798.303% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -5752.806% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 387.252% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -2834.635% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -170.407% |
| Pulmatrix, Inc. | -8.22 Million USD | -915.341% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -7033.42% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -20817.548% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 79.072% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 3106.97% |
| Cytokinetics, Incorporated | -322.59 Million USD | 74.128% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 9781.073% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -24375.371% |
| Vor Biopharma Inc. | -3.49 Million USD | -2290.063% |
| Roivant Sciences Ltd. | 109.23 Million USD | 176.405% |
| Evogene Ltd. | 1.39 Million USD | 6065.762% |
| ProKidney Corp. | -3.16 Million USD | -2533.67% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -90.064% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 1317.165% |
| CorMedix Inc. | -205.56 Thousand USD | -40501.384% |
| BioLineRx Ltd. | 1.1 Million USD | 7632.583% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -6.089% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -252812.17% |
| Atai Life Sciences N.V. | -5000.00 USD | -1669120.32% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -68389.825% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -86838.558% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -5908.712% |
| Sagimet Biosciences Inc. | 2 Million USD | 4273.051% |
| MediciNova, Inc. | 979.7 Thousand USD | 8618.995% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 1.018% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -88167.163% |
| GeoVax Labs, Inc. | -20.72 Million USD | -302.789% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 134.13% |
| Biomea Fusion, Inc. | -4.2 Million USD | -1886.694% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 109.568% |
| Mereo BioPharma Group plc | 7.42 Million USD | 1223.903% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -26822.908% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -695408.467% |
| Absci Corporation | -41.84 Million USD | -99.434% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1669120.32% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -9.281% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -3291.346% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 139.049% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -8769.396% |
| Allakos Inc. | -6.14 Million USD | -1259.079% |
| Imunon, Inc. | -720 Thousand USD | -11491.727% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -20.965% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 117.538% |
| BioAtla, Inc. | -103.73 Million USD | 19.541% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -731500.771% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -46788.211% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 65.628% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -26736.34% |
| XOMA Corporation | 3.86 Million USD | 2261.642% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -19.085% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 664.154% |
| aTyr Pharma, Inc. | -2.38 Million USD | -3395.017% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 769.832% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -287696.607% |
| Viridian Therapeutics, Inc. | -1 Million USD | -8179.863% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 642007915.385% |
| Akari Therapeutics, Plc | -4000.00 USD | -2086425.4% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 113.104% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 42964.708% |
| UroGen Pharma Ltd. | 73.35 Million USD | 213.782% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -212.658% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 718971.8% |
| Orgenesis Inc. | -5.72 Million USD | -1357.834% |
| Entera Bio Ltd. | -56 Thousand USD | -148937.529% |
| GH Research PLC | -315 Thousand USD | -26395.561% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -44059.268% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -15797.336% |
| Xencor, Inc. | -85.26 Million USD | 2.11% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -37669.096% |
| Replimune Group, Inc. | -2.65 Million USD | -3043.541% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -8235.799% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 146.929% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 42964.708% |
| Portage Biotech Inc. | -54 Thousand USD | -154457.437% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -88167.163% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -22038.201% |
| OncoCyte Corporation | 413 Thousand USD | 20308.478% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -1856652.303% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -37594952.252% |
| Purple Biotech Ltd. | -196 Thousand USD | -42482.151% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 1030.654% |
| scPharmaceuticals Inc. | 9.78 Million USD | 953.21% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -699.056% |
| HilleVax, Inc. | -2.15 Million USD | -3771.105% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -85942.285% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -556158.438% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -12394.164% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -362773.983% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -1111800.306% |
| Savara Inc. | -44.26 Million USD | -88.561% |
| Curis, Inc. | 9.81 Million USD | 950.688% |
| Daré Bioscience, Inc. | 2.76 Million USD | 3113.553% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -66782.245% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -4727.126% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -36505.709% |
| BeiGene, Ltd. | 2.07 Billion USD | 104.015% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -2885.122% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 79.117% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 247.229% |
| Erasca, Inc. | -3.73 Million USD | -2136.362% |
| bluebird bio, Inc. | -4.03 Million USD | -1970.993% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -295672.259% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 104.383% |
| DBV Technologies S.A. | 15.72 Million USD | 630.652% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -295672.259% |
| Moderna, Inc. | 2.15 Billion USD | 103.873% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -9021.423% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 1142.481% |
| Molecular Templates, Inc. | 50.39 Million USD | 265.614% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -15471.085% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 162.383% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -1241.386% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -112.137% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 24.897% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -2226.115% |
| MacroGenics, Inc. | 50.52 Million USD | 265.181% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -1268.662% |
| Prime Medicine, Inc. | -147.9 Million USD | 43.571% |
| Aditxt, Inc. | -111.66 Thousand USD | -74645.671% |
| Adagene Inc. | 18.11 Million USD | 560.818% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 17202.667% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 159.529% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 152.878% |
| SciSparc Ltd. | 2.19 Million USD | 3900.593% |
| Vericel Corporation | 135.57 Million USD | 161.56% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -333091.01% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -269285.501% |
| Generation Bio Co. | -73.91 Million USD | -12.921% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -18998.631% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 252.806% |
| Invivyd, Inc. | -2.02 Million USD | -4015.435% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 72.257% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -80586.997% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 186.607% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 184.915% |
| ADMA Biologics, Inc. | 88.21 Million USD | 194.608% |
| Clene Inc. | 533 Thousand USD | 15758.727% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 446.179% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -8621.109% |
| GeoVax Labs, Inc. | -20.72 Million USD | -302.789% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 4298.24% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -42851.181% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 267.576% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -1076.833% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -9883.375% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 200.055% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 114255.017% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 256.994% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 51.809% |
| Trevena, Inc. | 1.45 Million USD | 5836.152% |
| Surrozen, Inc. | -27.23 Million USD | -206.504% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -23543.347% |
| Cingulate Inc. | -582.91 Thousand USD | -14217.797% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -269129.084% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -323.681% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -1102423.329% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -9373.441% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 112.261% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -8347.471% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -148032.86% |
| Kronos Bio, Inc. | 1.37 Million USD | 6183.164% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -55.519% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -28482.54% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -16991.67% |
| ImmunityBio, Inc. | -17.89 Million USD | -366.523% |
| Korro Bio, Inc. | -3.63 Million USD | -2199.202% |
| Kineta, Inc. | 5.43 Million USD | 1636.187% |
| BioVie Inc. | -229.37 Thousand USD | -36285.957% |
| Codexis, Inc. | 57.33 Million USD | 245.57% |
| Celularity Inc. | 6.75 Million USD | 1335.544% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 2179.766% |
| Celcuity Inc. | -142.77 Thousand USD | -58357.552% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 165075.323% |
| Cibus, Inc. | 1.42 Million USD | 5969.27% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -22215.78% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -264.156% |
| IN8bio, Inc. | -2.5 Million USD | -3237.106% |
| Kodiak Sciences Inc. | -25.94 Million USD | -221.66% |
| Annexon, Inc. | -3.26 Million USD | -2454.668% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -3983.22% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -99.969% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 13140.784% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 110.721% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 148.256% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -4292.685% |
| Arcellx, Inc. | 108.27 Million USD | 177.08% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -157.842% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 205.375% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -294.577% |
| Moolec Science SA | -143.3 Thousand USD | -58140.128% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -97.223% |
| Geron Corporation | -123.5 Million USD | 32.422% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 2639.124% |
| Royalty Pharma plc | 1.79 Billion USD | 104.652% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -19.077% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -2310559.358% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 36169.258% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 25.089% |
| Humacyte, Inc. | -76.55 Million USD | -9.028% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -8693.015% |
| 89bio, Inc. | -273 Thousand USD | -30471.801% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -6539.699% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -9742.101% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -67754.485% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 7558.536% |
| Notable Labs, Ltd. | 113 Thousand USD | 73959.306% |
| Liquidia Corporation | 14.6 Million USD | 671.651% |
| Mustang Bio, Inc. | -2.22 Million USD | -3651.057% |
| Immunovant, Inc. | -231 Thousand USD | -36030.31% |
| Quantum-Si incorporated | 488 Thousand USD | 17202.667% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -50.221% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -278103.387% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 4582.332% |
| Acasti Pharma Inc. | -11 Thousand USD | -758636.509% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -40688.896% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -12770.769% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 50.176% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 7456.116% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -21805.778% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -4162.565% |
| PepGen Inc. | -1.18 Million USD | -6949.072% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -65617.335% |
| United Therapeutics Corporation | 2.07 Billion USD | 104.032% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -264.506% |
| Solid Biosciences Inc. | -76.56 Million USD | -9.01% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -100963.192% |
| Immuneering Corporation | -764.13 Thousand USD | -10822.244% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 126052.276% |
| Belite Bio, Inc | -399 Thousand USD | -20817.548% |
| XOMA Corporation | 3.86 Million USD | 2261.642% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -316.555% |
| Bionomics Limited | -434.44 Thousand USD | -19110.774% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -7671.044% |
| uniQure N.V. | 2.21 Million USD | 3867.992% |
| Cassava Sciences, Inc. | -89.42 Million USD | 6.667% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 9.349% |
| Forte Biosciences, Inc. | -9000.00 USD | -927244.622% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -9895.331% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -18998.631% |
| Altimmune, Inc. | -65.37 Million USD | -27.669% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 123.054% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -7671.044% |
| Compugen Ltd. | 31.45 Million USD | 365.335% |
| Peak Bio, Inc. | 367.76 Thousand USD | 22793.869% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 440.435% |
| Benitec Biopharma Inc. | 108 Thousand USD | 77378.719% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -106901.303% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -6837.74% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -4480.736% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -70035.308% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -6837.74% |
| Instil Bio, Inc. | -4.75 Million USD | -1654.857% |
| argenx SE | 1.1 Billion USD | 107.529% |
| Immunome, Inc. | -8.9 Million USD | -837.027% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -4315.927% |
| Verona Pharma plc | -679.62 Thousand USD | -12180.469% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -47592.009% |
| Shattuck Labs, Inc. | -2.38 Million USD | -3399.414% |
| CervoMed Inc. | -1.29 Million USD | -6351.706% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -3367.429% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -1647.143% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 3477.621% |
| Moolec Science SA | -143.3 Thousand USD | -58140.128% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -20354.627% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -3024.093% |
| AnaptysBio, Inc. | 14.78 Million USD | 664.651% |
| Design Therapeutics, Inc. | -537 Thousand USD | -15442.089% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -19445.905% |
| NeurAxis, Inc. | 2.15 Million USD | 3969.841% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 3989.143% |
| Lumos Pharma, Inc. | 2 Million USD | 4258.496% |
| Achilles Therapeutics plc | -4.73 Million USD | -1664.031% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -47592.009% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -78878.96% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 363.627% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 9781.073% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -7987.308% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -83.237% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 194195.386% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -10053.408% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -634198.647% |
| Palisade Bio, Inc. | 246 Thousand USD | 34027.242% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -252812.17% |
| Beam Therapeutics Inc. | -59.67 Million USD | -39.866% |
| Neurogene Inc. | -3.26 Million USD | -2458.584% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 159.9% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -2160.591% |
| Sesen Bio, Inc. | 40 Million USD | 308.653% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -28001.352% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -1972.517% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -772.476% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 692.763% |
| Athira Pharma, Inc. | -969 Thousand USD | -8513.108% |
| Vaccinex, Inc. | -16 Million USD | -421.501% |
| HCW Biologics Inc. | -574.82 Thousand USD | -14419.404% |
| XOMA Corporation | 3.86 Million USD | 2261.642% |
| Nektar Therapeutics | 53.47 Million USD | 256.066% |
| Arvinas, Inc. | 71.8 Million USD | 216.241% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -32.953% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -25819.57% |
| Rezolute, Inc. | -36 Thousand USD | -231736.156% |
| Clene Inc. | 533 Thousand USD | 15758.727% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -6499979.128% |
| BeyondSpring Inc. | 1.75 Million USD | 4866.477% |
| Synlogic, Inc. | -1.92 Million USD | -4237.891% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -225470.314% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -1218.083% |
| Peak Bio, Inc. | 367.76 Thousand USD | 22793.869% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -340.126% |
| Krystal Biotech, Inc. | 47.6 Million USD | 275.32% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 159.154% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 1760.916% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -3123.405% |
| MannKind Corporation | 136.19 Million USD | 161.282% |
| Ikena Oncology, Inc. | -50.49 Million USD | -65.296% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 176.701% |
| Gossamer Bio, Inc. | -4.38 Million USD | -1803.33% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -33019.451% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1669120.32% |
| Legend Biotech Corporation | 140.92 Million USD | 159.222% |
| Mural Oncology plc | -2.56 Million USD | -3151.306% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -15047.19% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -83361.016% |
| Champions Oncology, Inc. | 20.75 Million USD | 502.144% |
| REGENXBIO Inc. | 53.02 Million USD | 257.387% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -1457.994% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -43284.544% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -4718.765% |
| Vaxart, Inc. | -60.76 Million USD | -37.355% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -31660.795% |
| Cellectis S.A. | 18 Thousand USD | 463772.311% |
| Longeveron Inc. | 221 Thousand USD | 37865.166% |
| Repare Therapeutics Inc. | -80.07 Million USD | -4.235% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 107.636% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -6349.847% |
| Revolution Medicines, Inc. | -399.66 Million USD | 79.117% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -238360.046% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 170428.604% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 100.97% |
| Denali Therapeutics Inc. | -93.34 Million USD | 10.589% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -333091.01% |
| Veru Inc. | 7.56 Million USD | 1203.117% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -55172.196% |
| Cingulate Inc. | -582.91 Thousand USD | -14217.797% |
| Passage Bio, Inc. | -3.72 Million USD | -2142.973% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -692867.586% |
| Exicure, Inc. | -1.42 Million USD | -5765.145% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -21691.388% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 3187.718% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -16179.517% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 222.51% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -55686.839% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -40.967% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 21445.528% |
| OmniAb, Inc. | 14.66 Million USD | 669.039% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 517.451% |
| Lipocine Inc. | -2.85 Million USD | -2827.616% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -4428.541% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -1362.945% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -5440.829% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 210.814% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -128301.563% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 199.009% |
| Ocugen, Inc. | -33.53 Million USD | -148.862% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -2539.501% |
| Q32 Bio Inc. | 578 Thousand USD | 14539.622% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -31394.723% |
| Alumis Inc. Common Stock | -1.28 Million USD | -6400.079% |
| Equillium, Inc. | 35.95 Million USD | 332.107% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -4789.339% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 16769.566% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -2018792.501% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -32124.331% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 19844.179% |
| Dominari Holdings Inc. | 2.03 Million USD | 4193.233% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -45390.032% |
| vTv Therapeutics Inc. | -13.59 Million USD | -513.91% |
| Bio-Techne Corporation | 773.07 Million USD | 110.796% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 581.904% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 118.113% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -7039.522% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -248.044% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 813.525% |
| Nkarta, Inc. | -5.86 Million USD | -1322.065% |
| BioCardia, Inc. | -7.24 Million USD | -1051.345% |
| Iterum Therapeutics plc | -1.75 Million USD | -4669.201% |